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ABSTRACT
Objective: To screen various endophytic fungal metabolites toward anti-inflammatory, anticancer, and antioxidant property virtually.
Methods: In this study, 14 bioactive compounds reported from endophytic fungi have taken for structure-based drug design. With the help of software 
Schrodinger, different modules were used to perform screening of top active compounds. Ligprep, epharm, Glide, Quikprop are the modules were used from 
the software for our study. Identification of leads, pharmacophore model generation, and molecular docking studies were assessed using this software.
Results: After the screening of molecules virtually, the most bioactive anti-inflammatory compound was found to be cycloepoxytriol with the docking 
score of −7.511 kcal/mole, and the most active anticancer compound was found to be Phomol with the docking score of −9.778 kcal/mole. The most 
active antioxidant compound was found to be Phomol with the docking score of −9.970 kcal/mole. Further account the potential of the compounds 
to act as efficient drug candidates, their absorption, distribution, metabolism, and excretion properties were also predicted. All the compounds were 
shown to correlate well with all properties virtually.
Conclusion: In conclusion, using structure-based drug design, we have obtained some promising leads for anti-inflammatory, anticancer, and 
antioxidant drug discovery. The discovery of compounds from natural products is very potent for formulating new drugs.
Keywords: Endophytes, Anti-inflammatory, Anticancer, Antioxidant, Absorption; distribution; metabolism and excretion.
INTRODUCTION
Endophytic fungi are suggested to have played a major role in structuring 
plant communities and in shaping processes such as colonization, 
competition, coexistence, and soil nutrient dynamics. Endophytic fungal 
diversity is shaped by environmental or habitat conditions in which 
the plants take residence [1]. The search of a bioactive compound from 
isolated endophytic fungi and higher plants are considered for developing 
the therapeutic drugs. Thus, there is a need to isolate and synthesize 
the antibiotics and therapeutic from endophytic fungi, which are highly 
effective, low toxic and having minor environmental impact. The discovery 
of new and novel anti-inflammatory drugs is an area of intense interest in 
both pharmaceutical industry and academic laboratories [2]. Significant 
advances have been made in the treatment of inflammatory diseases such 
as rheumatoid arthritis and multiple sclerosis, but most dramatically with 
new biologic agents. Natural products and their derivatives represent 
more than 50% of all the drugs in clinical use worldwide. Higher plants 
contribute not less than 25% of the total [15]. Almost 60% of drugs 
approved for cancer treatment are of natural origin. A wide range of 
natural compounds has been reported for their antiproliferative and 
apoptosis triggering strategies in cancer cells. Reactive oxygen species, 
such as O2−, H2O2, and -OH, are generated byproducts of biological 
reactions, which can cause oxidative damage to biomolecules and play 
key roles in programmed cell death and stress-response signaling in 
conjunction with antioxidant production [3,16]. This study investigates 
endophytic fungi with anti-inflammatory, anticancer, and antioxidant 
activities to explore the potential sources of novel natural antibiotics. 
The preliminary screening of various endophytes for anti-inflammatory, 
anticancer, and antioxidant was developed for this study.
METHODS
Design of novel inhibitors using structure-based drug design
Computational details
The computational works were carried out in Windows 7 operating 
system with the intel I5 processor with the memory of 4 GB RAM. 
The desired modules Glide, Phase, LigPrep, and Quik prop were 
implemented with Maestro Software package (Schrodinger, LLC) 2016 
to perform our in-silico analysis. The bonding orders and charges were 
added to the hetero atoms, and the hydrogen atoms were added to all 
the atoms in the utilized protein molecule [4]. Furthermore, the water 
molecules have been removed to prevent from additional binding.
Protein preparation using protein preparation wizard
Initially, the protein preparation was performed using protein 
preparation wizard, and the energy minimization of the protein file 
was done. About 500 cycles of steepest descent (SD) and 5000 cycles 
of conjugate gradient methods with optimized potential for liquid 
simulations (OPLS) 2005 force field using Schrodinger suite version 9.3. 
Grid: A rectangular box surrounding the active site was located, and 
the grid file was generated using receptor grid generation panel. The 
“Write extra precision (XP) descriptor information” option was selected 
and “compute RMSD” option was enabled and rest of the parameters 
were kept as default [4]. The input RMSD of the crystal ligand was also 
calculated with the prepared ligand and the original ligand.
Development of energy-based pharmacophore models
Energy-based pharmacophore was employed for finding the bioactive 
component of ligands against the receptor was employed. The 
pharmacophore sites were generated using the PHASE module of 
the Schrodinger. For generation of e-pharmacophore docking post 
processing module option was selected and the input file has to be given 
in.xpdes format [4]. A default set of ten chemical features: Hydrogen 
bond acceptor (A), hydrogen bond donor (D), hydrophobic (H), 
negative ionisable (N), positive ionisable (P), and aromatic ring (R) 
features were used. Hydrogen bond acceptor sites were represented 
as vectors along the hydrogen bond axis in accordance with the 
hybridization of the acceptor atom. Hydrogen bond donors were 
represented as projected points, located at the corresponding 
hydrogen bond acceptor positions in the binding site. Projected points 
allowed the possibility for structurally dissimilar active compounds 
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to form hydrogen bonds to the same location, regardless of their 
point of origin and directionality. Each pharmacophore feature site 
was first assigned an energetic value equal to the sum of the Glide 
XP contributions of the atoms comprising the site, allowing sites. 
This allowed sites to be quantified and ranked on the basis of these 
energetic terms [4,5].
Preparation of ligands
The selected 14 endophytic bioactive molecules were processed 
through redundancy checking and Lipinski filters to select compounds 
that had better drug property (Fig. 1). All the structures were prepared 
using LigPrep (LigPrep v2.2, Schrodinger LLC, New York, NY) along 
with Epik (Epik v1.6, Schrodinger, LLC, New York, NY) to expand 
protonation and tautomeric states at 7.0±2.0 pH units. Conformational 
sampling was also performed for all database molecules using the 
ConfGen search algorithm. Confgen with OPLS 2005 force field 
was applied for the generation of conformers with duplicate poses 
eliminate if the RMSD was <2.0 Å. A distance-dependent dielectric 
constant of 4 and maximum relative energy difference of 10 kcal/mol 
were applied. Using phase, the database was indexed with automatic 
creation of pharmacophore sites for each conformer to allow rapid 
database alignments and screening.
Molecular docking
The predicted pharmacophore models were utilized to screen the 
14 bioactive compounds [1,2]. Molecular docking for the selected 
compounds was carried out by glide (grid based ligand docking with 
energetics). The glide module comes with the package of three modes 
of docking, high-throughput virtual screening (HTVS), standard 
precision (SP), and XP mode. The XP mode was used for exhaustive 
sampling and advanced scoring, resulting in even higher enrichment [5,6]. 
Final shortlisting of hit molecules were performed based on visual 
inspection of important amino acid interactions in the active site cavity, 
docking scores and the hydrogen bonds involved in binding [7,8].
Absorption, distribution, metabolism, and excretion (ADME) 
prediction
The selected 14 bioactive compounds were subjected to ADME 
prediction analysis using QikProp a module of Schrödinger. Various 
properties like LogP (octanol-water coefficient), % human oral 
absorption, Lipinski’s rule of five, QPlogBB (Predicted brain/blood 
partition coefficient), QPlogHERG (predicted inhibitory concentration 
values for blockage of HERG K+ QPPCaco (predicted apparent Caco-2 
cell permeability in nm/s) were predicted for the compounds and were 
checked for any violations [9].
Fig. 1: List of compounds taken for the study
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RESULTS
Developing novel endophytic bioactive compounds is one of the most 
promising drug targets for anti-inflammatory, anticancer, and antioxidant 
drug discovery. Structure-based drug designing was employed for 
screening of bioactive compounds. In this study, we have taken three 
different crystal structure (PDB ID: 4PH9, 4JSR and 5FVP) for screening 
of anti-inflammatory, anticancer, and antioxidant class of inhibitors. 
We have used HTVS, SP, and XP docking options for virtual screening of 
molecule [9]. Glide, phase and quickprop modules utilized for docking, 
screening and pharmacokinetic prediction with well-defined physics-
based scoring terms and thorough with sampling of database ligands.
Protein preparation and active site validation
The respective proteins for all the three targets were retrieved 
from the protein data bank, and the proteins were prepared using 
protein preparation wizard. The hydrogen atoms were added, water 
molecules were removed and the minimization of energy was done by 
converging the heavy atoms using OPLS_2005 force field. After protein 
preparation, grid: A rectangular box surrounding the active site pocket 
were validated, and the corresponding spaces were identified. The 
interaction of different ligands and the protein in the active site pocket 
were also identified [10,11].
Anti-inflammatory, anticancer, antioxidant enzyme target docking 
study
We attempted new drug design strategy, which was not explored for 
this target; we started with 3 inhibitor/substrate (ibuprofen, Sirt-3, and 
nitric oxide) bound with protein being crucial in the identification of 
novel lead bioactive molecules. The crystal ligand was made to docked 
into their respective proteins, and the docking score was found to be 
−9.75 kcal/mol, −11.73 kcal/mol and −6.637 kcal/mole, respectively, 
with the important amino acid interaction like (Arg121 and Try356), 
(Phe157, Glu296, Ile230, Arg158, Asp231 and Val292) and (Glu592 and 
Asn569). The three diagrammatic representation of crystal ligand in 
the active site of protein and its ligand interaction diagram are shown in 
Fig. 2a-c, respectively. After reference ligand docking, superimposition 
was calculated using original pose ligands and the docked poses ligands 
in the active site of the protein.
The RMSD were found to be <2 and the diagrammatic representation 
were depicted in Fig. 3a-c respectively.
Fig. 2: The three crystal ligand in the active site of protein and its ligand interaction. (a) Ibuprofen ligand bound with protein Cox-2, 
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After reference ligand docking studies, the energy-based 
pharmacophore hypothesis was developed by mapping energetic 
terms onto pharmacophore sites. The results of the e-phamacophore 
generation of the reference ligands were used to identify the best 
pharmacophore hypothesis. The energy contribution for binding of a 
ligand to the protein was the key to derive pharmacophoric features 
in structure-based design. The diagrammatic representation for the 
energy-based pharmacophores generated was depicted in Fig. 4a-c, 
respectively.
The first generated e-pharmacophore showed 1 aromatic ring and 
1 hydrophobe which is needed for the hydrophobic interaction within 
the pocket namely (R3) with its score (−1.05) and (H1) its score (0.63) 
and one negative ionisable group (N2) with the score of (−1.83). The 
second energy based pharmacophore hypothesis were developed and 
the features were found with two acceptors namely (A2 and A5) with 
the score (−2.20 and −0.75), two aromatic rings (R13 and R14) its score 
(0.77 and −1.45) required for hydrophobic interaction, and 3 donors 
(D6, D7 and D8) and their corresponding score of (−0.39, 0.62 and 0.35) 
and the third energy based pharmacophore hypothesis were developed 
and the features were found1acceptor, namely, (A1) with score (−0.67), 
two aromatic rings (R8 and R9) and their score (−1.05 and −0.89) 
1 hydrophobic (H1) interaction and its score (0.25) and 1 donors (D2) 
and its score (0.67). The energy score of the pharmacophoric features 
for all crystal structure is represented in Table 1a-c, respectively.
Virtual screening of natural products was crucial on in-silico drug 
discovery process as it helps in the selection of novel bioactive 
compounds. We have selected 14 molecules for our study (Fig. 1). Three 
docking strategies were used for our study. Top hits from HTVS with 
the docking score of −5.0 kcal/mol were subjected to secured screening 
using glide SP. Using XP docking analysis, it is very easy to predict 
hydrogen bond interactions, electrostatic interaction, hydrophobic 
interactions, and stacking interaction. Finally, XP docking studies were 
done for three targets and found that the most active compound after XP 
screening was cycloepoxytriol, phomol and phomol with docking score 
of −7.511 kcal/mol, −9.77 kcal/mol and −9.97 kcal/mol. Molecular 
docking studies were carried out, and the corresponding docking 
scores for all the targets were tabulated in Table 2a-c, respectively.
DISCUSSIONS
Developing novel endophytic bioactive compounds is one of the 
most promising drug targets for anti-inflammatory, anticancer, and 
antioxidant drug discovery. The screened 14 natural compounds 
were ranked based on the binding affinity, calculated as the scoring 
function called Glide score or docking score. The compounds were 
identified using phase find matches using phase module available in the 
Schrodinger Software.
Cyclooxygenase-2 enzyme was retrieved from protein data bank for 
anti-inflammatory drug screening. The reference ligand after docking 
was found to well fit into the active site of the enzyme cavity. The 
closer analysis of the molecule was found that the compound has two 
important interaction with Arg121 and Tyr356. Fuethermore, the 
ligand was entirely surrounded with hydrophobic amino acids Phe519, 
Trp388, Met523 and Leu353. On screening of 14 natural bioactive 
compounds, the most active compound cycloepoxytriol after XP 
Table 1: Anti-inflammatory, anticancer and antioxidant energy 
based pharmacophore features and its scores
a. Energy-based pharmacophore generation for virtual 
screening of compounds (Ibuprofen bound with Cox-2)
Feature label Score Score source
N2 −1.83 Negative ionisable
H1 0.63 Hydrophobe
R3 −1.05 Aromatic ring
b. Energy-based pharmacophore generation for virtual 
screening of compounds (NAD+ bound with SIRUTIN)
A5 −0.75 Hydrogen bond acceptor
D6 −0.39 Hydrogen bond donor
D7 −0.62 Hydrogen bond donor
D8 −0.35 Hydrogen bond donor
A2 −2.2 Acceptor
R13 −0.77 Ring group
R14 −1.45 Ring group
c. Energy-based pharmacophore generation for virtual 
screening of compounds (nitric oxide inhibitor bound with 
nitric oxide synthase)
A1 −0.67 Hydrogen bond acceptor
A2 −0.67 Hydrogen bond donor
H7 −0.25 Hydrophobe
R9 −0.89 Ring group
R8 −1.05 Ring group
Fig. 3: The three superimposition of docked pose of ibuprofen, 
NAD+, Nitric oxide inhibitor and original pose of ibuprofen, 
NAD+ and Nitric oxide Inhibitor; (where grey color indicates the 
original ligand and the violet color represents docked ligand), 
(where violet color indicates the original ligand and the pink 
color represents docked ligand), (where yellow color indicates 
the original ligand and the red color represents docked ligand). 
(a) Ibuprofen ligand with protein, (b) NAD+ ligand with protein, 
(c) nitric oxide inhibitor
a b
c
Fig. 4: The three energy-based pharmacophore generation 
for virtual screening of compounds. (a) Ibuprofen ligand with 
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docking analysis was found to be −7.511 kcal/mol. The binding analysis 
of the protein and ligand was depicted in Fig. 5a. On closer analysis, the 
ligand was found to interact with an amino acid Tyr356 which is similar 
to the reference ligand and also the hydroxyl moiety was surrounded 
by hydrophobic amino acids like Phe519, Val524 and Met523. As this 
molecule was found to well buried into the active site pocket which 
makes this molecule a top active molecule than others [17].
SIRUTIN-3 enzyme was taken for anticancer study as SIRT-3 gene 
is over-expressed in most of the cancers such as lung and prostrate. 
A similar way of the study was performed for this target too [12,13]. 
The reference ligand NAD+ was found to interact with positively charged 
amino acid like Glu296, Arg158, and Asp231. After three different 
docking analysis, the most active compound Phomol was found to be 
interact with amino acids Phe157 and Tyr165 with the binding score 
of −9.77 kcal/mol. The three dimensional view of the ligand and the 
protein reveals that the most active compound was well buried into 
the active site pocket of the protein which makes this molecule a better 
target than other compounds which were screened for the docking 
analysis. The binding analysis and the ligand interaction of the protein 
with ligand were shown in Fig. 5b.
Nitric oxide synthase enzyme crystal structure complexed with inhibitor 
was taken for our study to discover novel hit molecule for antioxidant 
drug discovery. The reference ligand was docked into the active site of 
the enzyme, and the docking score was found to be −6.637 kcal/mol. 
The reference ligand was found to interact with positively charged 
amino acid Asn569 and stacking interaction with Glu592. After three 
different docking strategies, the compound Phomol was found to be 
−9.970 kcal/mol. The closer analysis of the compound was analyzed 
and found that the compound was found to interact with the amino 
acids Glu592 and Trp587 also the propyl group of this compound was 
found to interact with non-polar amino acid Ala475, Phe584, Ile459 and 
Leu424 amino acids. The binding analysis and the ligand interaction 
diagram for the most active compound were shown in Fig. 5c.
To further account for the potential of the compounds to act as efficient 
drug candidates, their ADME properties were also predicted using 
quickprop module in Schrodinger. The obtained values for molecular 
logP, HERG property, Caco accessibility, blood–brain barrier, and human 
oral absorption; it is also used to access violation of Lipinski’s rule of 
five for the prompt drug candidate. All the compounds were shown to 
correlate well with the human oral absorption; blood–brain barrier 
separates the human brain from the direct contact of circulatory 
system, thus protecting the brain for unwanted solute particles. Both 
the most active compounds shown to be blood brain barrier negative 
ensuring their administration safe for the brain. Furthermore, all the 
compounds followed Lipinski’s rule of five. The ADME prediction for all 
the compounds was reported in Table 3.
CONCLUSION
In conclusion, using structure-based drug design, we have obtained 
some promising leads for anti-inflammatory, anticancer, and antioxidant 
drug discovery. The discovery of compounds from natural products is 
very potent for formulating new drugs. Endophytic fungi are producing 
more bioactive compounds analogs similar to their hosts. Based on 
our analysis, we can say that the endophytic fungi could be a reliable 
source for pharmaceutically and industrially important compounds for 
drug discovery and development. Based on our study, we have found 
that the most active anti-inflammatory compound was found to be 
cycloepoxytriol with the docking score of −7.511 kcal/mole and the 
binding analysis of the compound was found to be that the compound 
was well buried into the active of the protein which implies the high 
activity of the compound make this molecule more potent. The most 
active anticancer compound was found to be Phenol with the docking 
score of −9.778 kcal/mole and the binding analysis of the compound 
Table 2: Docking analysis and their scores for the top leads
Compounds HTVS 
kcal/mol
SP kcal/mol XP kcal/mol
a. Anti-inflammatory 
target
Cycloepoxytriol −5.673 −7.354 −7.511
Cycloepoxylactone −4.977 −7.148 −7.428
Phyllostine −6.283 −6.800 −6.429
Phomoxanthone A −6.065 −6.645 −5.356
3-Nitropropionic acid −4.413 −5.524 −5.992
Epioxydon −5.722 −5.790 −4.901
b. Anticancer target
Phomol −6.547 −7.247 −9.778
Phomodione −6759 −8.362 −9.260
Phomoxanthone −7.610 −7.763 −7.092
Cycloepoxylactone −6.441 −6.491 −6.991
Phomosine −5.731 −6.593 −6.758
Epioxydon −5.075 −7.098 −6.375
Cycloepoxytriol −6.290 −6.290 −5.670
3-nitropropionic acid −3.564 −4.349 −2.637
c. Anti-oxidant target




Phomoxanthone A −3.943 −5.194 −7.795
Cycloepoxylactone −4.193 −5.214 −6.646
Trihydroxy-p-methane −5.064 −5.279 −5.840
Phyllostine −4.560 −5.279 −5.561
Cycloepoxytriol B −4.035 −4.366 −5.327
Phomodione −4.824 −4.837 −5.285
Epioxydon −4.453 −4.969 −3.496
3-Nitropropionic acid −4.343 −5.103 −3.177
Dicerandrol A −2.524 −3.438 −0.166
HTVS: High-throughput virtual screening
Table 3: ADME prediction for the natural endophytic bioactive compounds
Compound ID QPlogPo/wa QPlogHERGb QPPCacoc QPlogBBd % Human oral absorptione Rule of fivef
Cycloepoxylactone 0.109 −3.007 462.605 −0.808 75.288 0
Cycloepoxytriol −0.269 −2.549 653.53 −0.681 75.76 0
3-Nitropropionic acid −0.542 −0.83 25.898 −1.226 49.065 0
Dicerandrol 3.87 −5.88 6.588 −3.993 38.344 2
Phomodione 1.09 −3.469 338.281 −1.129 78.599 0
Phomol 2.844 −4.882 223.94 −1.918 85.658 0
Phomosine G 3.492 −4.202 675.49 −0.725 100 0
Phomoxanthone 2.953 −4.456 15.852 −2.779 39.801 2
Phyllostine −1.966 −1.122 307.145 −0.556 59.951 0
Trihydroxy-p-menthane 1.348 −2.817 1464.461 −0.366 91.501 0
aPredicted octanol/water partition coefficient logP (acceptable range: −2.0-6.5); bPredicted IC50 value for blockage of HERG K+channels (below −5); cPredicted apparent 
Caco-2 cell permeability in nm/seconds (<25 poor; >500 great); dPredicted brain/blood partition coefficient (−3.0-1.2); ePercent human oral absorption (<25% is poor 
and >80% is high); fRule of 5 violation (mol_MW <500, QPlogPo/w <5, donorHB £≤5, accptHB £≤10), IC50: Inhibitory concentration, ADMA: Absorption, distribution, 
metabolism and excretion
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found to be interact with the amino acid interaction Phe157 and 
Tyr165. The most active antioxidant compound was found to be Phenol 
with the docking score of −9.970 kcal/mole and the binding analysis 
was found to be interacting with Trp587 and Glu592. The molecule 
was buried with the hydrophobic pocket which shows the activity of 
the molecule. To conclude, the natural endophyte Phomol was found to 
be most active according to structure-based drug design strategy. The 
most active bioactive compounds did not show any violation in ADME 
predication using quickprop as a module in Schrodinger. Further the 
top active compounds after virtual screening will be carried out for 
their in-vitro analysis, QSAR analysis [18] and to prove the better target 
for anti-inflammatory, anticancer, and antioxidant targets.
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